<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
      version="3.7"
      xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
   <titleInfo>
      <title>Elucidation of the hepatoprotective effect and mechanism of Melastoma dodecandrum Lour. based on network pharmacology and experimental validation</title>
   </titleInfo>
   <name type="personal" usage="primary">
      <namePart type="given">Jinfeng</namePart>
      <namePart type="family">Wang</namePart>
      <nameIdentifier type="orcid">https://orcid.org/0000-0002-3431-3641</nameIdentifier>
      <displayForm>Wang, Jinfeng</displayForm>
      <affiliation>School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102488, China</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Linyuan</namePart>
      <namePart type="family">Wang</namePart>
      <displayForm>Wang, Linyuan</displayForm>
      <affiliation>School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Zhihao</namePart>
      <namePart type="family">Zhang</namePart>
      <displayForm>Zhang, Zhihao</displayForm>
      <affiliation>School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 211198, China</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Min</namePart>
      <namePart type="family">Wu</namePart>
      <displayForm>Wu, Min</displayForm>
      <affiliation>Medical College, Yangzhou University, Yangzhou, 225001, China</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Wenting</namePart>
      <namePart type="family">Fei</namePart>
      <displayForm>Fei, Wenting</displayForm>
      <affiliation>School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Zhihui</namePart>
      <namePart type="family">Yang</namePart>
      <displayForm>Yang, Zhihui</displayForm>
      <affiliation>Department of Emergency Medicine, University of Florida, Gainesville, 32611, USA</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Jianjun</namePart>
      <namePart type="family">Zhang</namePart>
      <displayForm>Zhang, Jianjun</displayForm>
      <affiliation>School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 102488, China</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <typeOfResource>text</typeOfResource>
   <genre>article</genre>
   <originInfo>
      <dateIssued encoding="w3cdtf" keyDate="yes">2022-01</dateIssued>
   </originInfo>
   <language>
      <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
      <languageTerm type="text">English</languageTerm>
   </language>
   <abstract>To systematically explore the effect and mechanism of melastomatis dodecandri herba (Melastoma dodecandrum Lour.) in the treatment of hepatitis based on network pharmacology. We evaluated the hepatoprotective effects of M. dodecandrum in concanavalin A (Con A)-induced hepatitis in mice by assessing survival rate, histological analysis, serum transaminases, and related cytokines. Then the mechanism of action was predicted by a network pharmacology-based strategy. Based on the results, we measured the hepatic expression of related genes at mRNA level and proteins related to the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) and nuclear factor-kappa B (NF-кB) pathways. Our study results clearly demonstrated that M. dodecandrum pretreatment significantly alleviated liver injury. This was demonstrated by an increase in survival rate, decreased severity of liver damage, and reduced serum transaminase levels compared with those in the Con A group. Moreover, M. dodecandrum significantly reduced the serum levels of tumor necrosis factor-α, interleukin-6, and interferon-γ and increased the liver levels of superoxide dismutase, which indicated that M. dodecandrum exhibits anti-inflammatory and antioxidant activities. On the basis of network pharmacology, 50 nodes were selected as major hubs based on their topological importance. Pathway enrichment analyses indicated that the putative targets of M. dodecandrum mostly participate in various pathways associated with the anti-inflammation response, which implies the underlying mechanism by which M. dodecandrum acts on hepatitis. Real-time fluorescent quantitative PCR analysis showed that M. dodecandrum downregulates the mRNA expression of interleukin-6, Toll-like receptor 7, interleukin-1 receptor-associated kinase-4, NF-кB and tumor necrosis factor-α in liver tissues. Western blotting showed that M. dodecandrum pretreatment protected against inflammation through activating the PI3K-Akt pathway by upregulating phosphorylated Akt (p-Akt) expression and suppressing NF-кB activation by inhibiting the phosphorylation of IKK, IκBα, and p65. The present work demonstrated the hepatoprotective effects of M. dodecandrum by regulating the PI3K/Akt and NF-кB pathways in Con A-induced mice, which provide insights into the treatment of hepatitis using M. dodecandrum. </abstract>
   <subject>
      <topic>Melastoma dodecandrum Lour.</topic>
   </subject>
   <subject>
      <topic>Concanavalin A</topic>
   </subject>
   <subject>
      <topic>Hepatitis</topic>
   </subject>
   <subject>
      <topic>Network pharmacology</topic>
   </subject>
   <subject>
      <topic>Inflammation</topic>
   </subject>
   <subject>
      <topic>Mechanism</topic>
   </subject>
   <subject>
      <topic>Phosphoinositide 3-kinase (PI3K)/protein kinase B</topic>
   </subject>
   <subject>
      <topic>Nuclear factor-kappa B</topic>
   </subject>
   <relatedItem type="host">
      <titleInfo>
         <title>Journal of Traditional Chinese Medical Sciences</title>
      </titleInfo>
      <name type="corporate">
         <namePart>Beijing University of Chinese Medicine</namePart>
         <role>
            <roleTerm>Copyright holder</roleTerm>
         </role>
      </name>
      <originInfo>
         <publisher>Elsevier B.V.</publisher>
      </originInfo>
      <identifier type="issn">2095-7548</identifier>
      <part>
         <detail type="volume">
            <number>9</number>
            <caption>v.</caption>
         </detail>
         <detail type="issue">
            <number>1</number>
            <caption>no.</caption>
         </detail>
         <text type="display-date">January 2022</text>
         <text type="year">2022</text>
         <text type="month">January</text>
         <extent unit="pages">
            <start>47</start>
            <end>58</end>
            <total xmlns="http://www.loc.gov/mods/v3">12</total>
         </extent>
      </part>
   </relatedItem>
   <identifier type="doi">10.1016/j.jtcms.2021.12.003</identifier>
   <location>
      <url>http://dx.doi.org/10.1016/j.jtcms.2021.12.003</url>
   </location>
   <identifier type="pii">S2095-7548(21)00101-0</identifier>
   <accessCondition type="use and reproduction"
                    displayLabel="Creative Commons Attribution 4.0 Generic (CC BY-NC-ND 4.0)">
      <program xmlns="https://data.crossref.org/schemas/AccessIndicators.xsd">
         <licence_ref applies_to="reuse" start_date="2021-12-31"/>
         <licence_ref>http://creativecommons.org/licenses/by-nc-nd/4.0/</licence_ref>
      </program>
   </accessCondition>
   <extension>
      <vendorName/>
      <archiveFile/>
      <originalFile>file:/C:/Users/Carlos.Martinez/OneDrive%20-%20USDA/XML_projects/OpenAccess/OpenAccess/transform/source/sourcefiles/576450669703096969-00001/2095-7548/S2095754822X00021/S2095754821001010/S2095754821001010.xml</originalFile>
      <workingDirectory>C:\Users\Carlos.Martinez\OneDrive - USDA\XML_projects\OpenAccess\OpenAccess\transform\result\</workingDirectory>
   </extension>
</mods>
